LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 10 von insgesamt 667

Suchoptionen

  1. Artikel ; Online: Advances in physiology, design and development of novel medications changing the landscape of obesity pharmacotherapy.

    Chakhtoura, Marlene / Mantzoros, Christos S

    Metabolism: clinical and experimental

    2023  Band 142, Seite(n) 155531

    Mesh-Begriff(e) Humans ; Obesity/drug therapy ; Anti-Obesity Agents/therapeutic use
    Chemische Substanzen Anti-Obesity Agents
    Sprache Englisch
    Erscheinungsdatum 2023-03-03
    Erscheinungsland United States
    Dokumenttyp Editorial
    ZDB-ID 80230-x
    ISSN 1532-8600 ; 0026-0495
    ISSN (online) 1532-8600
    ISSN 0026-0495
    DOI 10.1016/j.metabol.2023.155531
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Sarcopenia: still in relative definition-penia and severe treatment-penia.

    Polyzos, Stergios A / Mantzoros, Christos S

    Metabolism: clinical and experimental

    2023  Band 150, Seite(n) 155717

    Mesh-Begriff(e) Humans ; Sarcopenia/therapy ; Muscle Strength ; Muscle, Skeletal/pathology ; Hand Strength
    Sprache Englisch
    Erscheinungsdatum 2023-11-03
    Erscheinungsland United States
    Dokumenttyp Editorial
    ZDB-ID 80230-x
    ISSN 1532-8600 ; 0026-0495
    ISSN (online) 1532-8600
    ISSN 0026-0495
    DOI 10.1016/j.metabol.2023.155717
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Buch ; Online: Obesity and Diabetes

    Mantzoros, Christos S.

    2006  

    Verfasserangabe edited by Christos S. Mantzoros
    Schlagwörter Endocrinology
    Sprache Englisch
    Verlag Humana Press Inc
    Erscheinungsort Totowa, NJ
    Dokumenttyp Buch ; Online
    HBZ-ID TT050387100
    ISBN 978-1-588-29538-5 ; 978-1-592-59985-1 ; 1-588-29538-9 ; 1-592-59985-0
    DOI 10.1007/978-1-59259-985-1
    Datenquelle ZB MED Katalog Medizin, Gesundheit, Ernährung, Umwelt, Agrar

    Kategorien

  4. Buch: Nutrition and metabolism

    Mantzoros, Christos S.

    underlying mechanisms and clinical consequences

    (Nutrition and health)

    2009  

    Verfasserangabe ed. Christos S. Mantzoros
    Serientitel Nutrition and health
    Schlagwörter Obesity ; Nutritional Physiological Phenomena ; Diabetes Mellitus, Type 2 ; Metabolic Syndrome X ; Metabolism/Diseases ; Nutrition
    Thema/Rubrik (Code) 613.2
    Sprache Englisch
    Umfang XX, 423, IV S. : Ill., graph. Darst.
    Verlag Humana Press
    Erscheinungsort New York, NY
    Erscheinungsland Vereinigte Staaten
    Dokumenttyp Buch
    HBZ-ID HT015585446
    ISBN 1-60327-452-9 ; 978-1-60327-452-4 ; 9781603274531 ; 1603274537
    Datenquelle Katalog ZB MED Ernährung, Umwelt, Agrar

    Zusatzmaterialien

    Kategorien

  5. Buch: Nutrition and metabolism

    Mantzoros, Christos S.

    underlying mechanisms and clinical consequences

    (Nutrition and health)

    2009  

    Verfasserangabe ed. Christos S. Mantzoros
    Serientitel Nutrition and health
    Schlagwörter Obesity ; Nutritional Physiological Phenomena ; Diabetes Mellitus, Type 2 ; Metabolic Syndrome X ; Metabolism/Diseases ; Nutrition
    Thema/Rubrik (Code) 613.2
    Sprache Englisch
    Umfang XX, 423, IV S. : Ill., graph. Darst.
    Verlag Humana Press
    Erscheinungsort New York, NY
    Erscheinungsland Vereinigte Staaten
    Dokumenttyp Buch
    HBZ-ID HT015585446
    ISBN 1-60327-452-9 ; 978-1-60327-452-4 ; 9781603274531 ; 1603274537
    Datenquelle Katalog ZB MED Medizin, Gesundheit

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Metreleptin for the treatment of lipodystrophy: leading the way among novel therapeutics for this unmet clinical need.

    Polyzos, Stergios A / Mantzoros, Christos S

    Current medical research and opinion

    2022  Band 38, Heft 6, Seite(n) 885–888

    Mesh-Begriff(e) Humans ; Leptin/analogs & derivatives ; Leptin/therapeutic use ; Lipodystrophy/drug therapy
    Chemische Substanzen Leptin ; metreleptin (TL60C27RLH)
    Sprache Englisch
    Erscheinungsdatum 2022-04-12
    Erscheinungsland England
    Dokumenttyp Editorial
    ZDB-ID 80296-7
    ISSN 1473-4877 ; 0300-7995
    ISSN (online) 1473-4877
    ISSN 0300-7995
    DOI 10.1080/03007995.2022.2059974
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Cross-talk between SARS-CoV-2 infection and the insulin/IGF signaling pathway: Implications for metabolic diseases in COVID-19 and for post-acute sequelae of SARS-CoV-2 infection.

    Kelesidis, Theodoros / Mantzoros, Christos S

    Metabolism: clinical and experimental

    2022  Band 134, Seite(n) 155267

    Mesh-Begriff(e) COVID-19/complications ; Disease Progression ; Humans ; Insulin ; Metabolic Diseases/etiology ; SARS-CoV-2 ; Signal Transduction ; Post-Acute COVID-19 Syndrome
    Chemische Substanzen Insulin
    Sprache Englisch
    Erscheinungsdatum 2022-07-25
    Erscheinungsland United States
    Dokumenttyp Editorial
    ZDB-ID 80230-x
    ISSN 1532-8600 ; 0026-0495
    ISSN (online) 1532-8600
    ISSN 0026-0495
    DOI 10.1016/j.metabol.2022.155267
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Buch: Obesity and diabetes

    Mantzoros, Christos S.

    (Contemporary diabetes)

    2006  

    Verfasserangabe ed. by Christos S. Mantzoros
    Serientitel Contemporary diabetes
    Schlagwörter Diabetes Complications / complications ; Obesity / complications ; Obesity / physiopathology ; Diabetes Mellitus / physiopathology ; Diabetes mellitus ; Fettsucht
    Schlagwörter Adipositas ; Fettleibigkeit ; Korpulenz ; Obesität ; Obesity ; Diabetes verus ; Zuckerharnruhr ; Zuckerkrankheit
    Sprache Englisch
    Umfang XVII, 555 S. : Ill., graph. Darst.
    Verlag Humana Press
    Erscheinungsort Totowa
    Erscheinungsland Vereinigte Staaten
    Dokumenttyp Buch
    HBZ-ID HT014354790
    ISBN 1-58829-538-9 ; 978-1-58829-538-5
    Datenquelle Katalog ZB MED Medizin, Gesundheit

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on.

    Boutari, Chrysoula / Mantzoros, Christos S

    Metabolism: clinical and experimental

    2022  Band 133, Seite(n) 155217

    Abstract: The WHO just released in May 2022 a report on the state of the obesity pandemic in Europe, stating that 60% of citizens in the area of Europe are either overweight or obese, and highlighting the implications of the obesity pandemic, especially as it ... ...

    Abstract The WHO just released in May 2022 a report on the state of the obesity pandemic in Europe, stating that 60% of citizens in the area of Europe are either overweight or obese, and highlighting the implications of the obesity pandemic, especially as it interacts with the COVID pandemic to create a twin pandemic, to increase morbidity and mortality. Obesity is a complex disease which has reached pandemic dimensions. The worldwide prevalence of obesity has nearly tripled since 1975, mainly due to the adoption of a progressively more sedentary lifestyle and the consumption of less healthy diets. We first report herein updated prevalence rates of overweight and obesity by sex, age, and region first in Europe, per the WHO report, and then worldwide between 1980 and 2019, as we analyze and present herein the data provided by the Global Burden of Disease Study. The prevalence of obesity is higher in women than in men of any age and the prevalence of both overweight and obesity increases with age and has reached their highest point between the ages of 50 to 65 years showing a slight downward trend afterwards. The age-standardized prevalence of obesity has increased from 4.6% in 1980 to 14.0% in 2019. The American and European region have the highest obesity prevalence and the USA and Russia are the countries with the most obese residents. Given dire implications in terms of comorbidities and mortality, these updated epidemiological findings call for coordinated actions from local and regional governments, the scientific community and individual patients alike, as well as the food industry for the obesity pandemic to be controlled and alleviated. We can hopefully learn from the COVID-19 pandemic, where collaborative efforts worldwide, focused intense work at both the local and global level and well-coordinated leadership have demonstrated that humankind is capable of amazing accomplishments by leveraging science and public health, and that we can finally make strides in terms of understanding and combating the obesity pandemic and its dire comorbidities including diabetes, NAFLD, CVD and obesity associated malignancies.
    Mesh-Begriff(e) Aged ; Body Mass Index ; COVID-19/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Obesity/epidemiology ; Overweight/epidemiology ; Pandemics ; Prevalence
    Sprache Englisch
    Erscheinungsdatum 2022-05-15
    Erscheinungsland United States
    Dokumenttyp Editorial
    ZDB-ID 80230-x
    ISSN 1532-8600 ; 0026-0495
    ISSN (online) 1532-8600
    ISSN 0026-0495
    DOI 10.1016/j.metabol.2022.155217
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Obesity and diabetes.

    Boutari, Chrysoula / DeMarsilis, Antea / Mantzoros, Christos S

    Diabetes research and clinical practice

    2023  Band 202, Seite(n) 110773

    Abstract: Obesity, which has currently reached pandemic dimensions, is usually accompanied by diabetes mellitus type 2 (T2DM). These two conditions share common pathophysiological mechanisms. Adipose tissue secretes cytokines which are involved in inflammation and ...

    Abstract Obesity, which has currently reached pandemic dimensions, is usually accompanied by diabetes mellitus type 2 (T2DM). These two conditions share common pathophysiological mechanisms. Adipose tissue secretes cytokines which are involved in inflammation and various endocrine functions. As for T2DM, it is characterized also by inflammation, mitochondrial dysfunction, and hyperinsulinemia. These conditions occur also in other diseases related to obesity and T2DM, like cardiovascular disease (CVD) and nonalcoholic fatty liver disease (NAFLD). Thus, management of obesity-related complications with lifestyle modification, anti-obesity drugs, and bariatric surgery, all contribute to improvement in any of these conditions. This review provides an overview of the literature addressing the association between obesity and T2DM, briefly discussing the pathophysiological mechanisms linking these conditions and outlining the management approach at the overlap of obesity and T2DM.
    Mesh-Begriff(e) Humans ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/epidemiology ; Diabetes Mellitus, Type 2/therapy ; Obesity/complications ; Obesity/epidemiology ; Obesity/therapy ; Non-alcoholic Fatty Liver Disease/complications ; Cytokines ; Inflammation/complications
    Chemische Substanzen Cytokines
    Sprache Englisch
    Erscheinungsdatum 2023-06-23
    Erscheinungsland Ireland
    Dokumenttyp Review ; Journal Article
    ZDB-ID 632523-3
    ISSN 1872-8227 ; 0168-8227
    ISSN (online) 1872-8227
    ISSN 0168-8227
    DOI 10.1016/j.diabres.2023.110773
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang